Vegetos

---

Research Articles | Published: 15 June, 2026

References

---

Ahmed ES, Mohamed HE, Farrag MA (2022) Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K/AKT/FoxO1 pathway. Int J Immunopathol Pharmacol 36:3946320221137435. https://doi.org/10.1177/03946320221137435


Alam MN, Bristi NJ, Rafiquzzaman M (2013) Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm J 21(2):143–152


Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B, Cseh J et al (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Brit J Nutr 2011(106):383–389. https://doi.org/10.1017/s0007114511000316


Cabrera D, Wree A, Povero D, Solís N, Hernandez A, Pizarro M et al (2017) Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis. Sci Rep 7(1):3491


Chang TN, Deng JS, Chang YC, Lee CY, Jung-Chun L, Lee MM et al (2012) Ameliorative effects of scopoletin from Crossostephium chinensis against inflammation pain and its mechanisms in mice. Evid Based Complem Altern Med 2012(1):595603


Chen P, Zhu Z, Geng H, Cui X, Han Y, Wang L (2024) Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease. J Pharm Anal 14(4):100910. https://doi.org/10.1016/j.jpha.2023.11.017


Ciorsac A, Filip M, Isvoran A (2021) Predict of water solubility of the low molecular weigh oligomers of polyhydroxyalkanoates. New Front Chem 30(1):25–34


Coleta M, Campos MG, Cotrim MD, Lima TC, Cunha AP (2008) Assessment of luteolin (3′,4′,5,7-tetrahydroxyflavone) neuropharmacological activity. Behav Brain Res 189(1):75–82. https://doi.org/10.1016/j.bbr.2007.12.010


Cuong TT, Thien DD, Yen HH, Duc NA, Nam TQ (2024) Wedelolactone from Eclipta prostrata (L.) L suppresses inflammation and improves insulin resistance. Asian Pac J Trop Biomed 14(6):253–258


Dascălu D, Roman DL, Filip M, Ciorsac AA, Ostafe V, Isvoran A (2020) Solubility and ADMET profiles of short oligomers of lactic acid. ADMET DMPK 8(4):425–436. https://doi.org/10.5599/admet.843


Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR (2016) Beneficial action of resveratrol: How and why? Nutrition 32:174–178. https://doi.org/10.1016/j.nut.2015.08.017


Du DX, Khang NHD, Tri NH, Nam PC, Thong NM (2023) Exploring the multitarget activity of wedelolactone against Alzheimer’s disease: insights from in silico study. ACS Omega 8(17):15031–15040


Elmeliegy M, Vourvahis M, Guo C, Wang DD (2020) Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug–drug interaction studies. Clin Pharmacokinet 59:699–714


Fernandez-Quintela A, Carpene C, Fernandez M, Aguirre L, Milton-Laskibar I, Contreras J et al (2017) Anti-obesity effects of resveratrol: comparison between animal models and humans. J Physiol Biochem 73:417–429. https://doi.org/10.1007/s13105-016-0544-y


Gláucia SV, Marques ASF, Machado MTC, Silva VM, Hubinger MD (2017) Determination of anthocyanins and non-anthocyanin polyphenols by ultra-performance liquid chromatography/electrospray ionization mass spectrometry (UPLC/ESI–MS) in jussara (Euterpe edulis) extracts. J Food Sci Technol 54:2135–2144


Gumieniczek A, Berecka-Rycerz A, Dul M, Pryjda A (2025) Standardized chromatographic and computational approaches for lipophilicity analysis of five gliflozin antidiabetic drugs in relation to their biological activity. Molecules 30(1):115. https://doi.org/10.3390/molecules30010115


Guo W, Luo L, Meng Y, Chen W, Yu L, Zhang C et al (2022) Luteolin alleviates methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiome. Front Nutr 9:936237


Gupta MK, Senthilkumar S, Chiranjivi AK, Banik K, Girisa S, Kunnumakkara AB et al (2021) Antioxidant, anti-tyrosinase and anti-inflammatory activities of 3, 5-dihydroxy-4′, 7-dimethoxyflavone isolated from the leaves of Alpinia nigra. Phytomedicine plus 1(3):100097


Hu, J., Pang, D., Tian, N., Qin, R. 2024. Luteolin ameliorates nonalcoholic fatty liver disease via regulation of hepatic lipid uptake, autophagy, and apoptosis in WD/CCl4-induced mice. Pharmacogn Mag 09731296241258540


Hui Y, Wang X, Yu Z, Fan X, Cui B, Zhao T et al (2020) Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action. Pharmacol Res 160:105170


Ibrahim KA, Abdelgaid HA, Eleyan M, Mohamed RA, Gamil NM (2022) Resveratrol alleviates cardiac apoptosis following exposure to fenitrothion by modulating the sirtuin1/c-Jun N-terminal kinases/p53 pathway through pro-oxidant and inflammatory response improvements: In vivo and in silico studies. Life Sci 290:120265. https://doi.org/10.1016/j.lfs.2021.120265


Ji LL, Wang Z, Dong F, Zhang WB, Wang ZT (2005) Andrograpanin, a compound isolated from anti-Inflammatory traditional Chinese medicine Andrographis paniculata, enhances chemokine SDF-1α-induced leukocytes chemotaxis. J Cell Biochem 95(5):970–978


Kim HJ, Jang SI, Kim YJ, Chung HT, Yun YG, Kang TH et al (2004) Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia 75(3–4):261–266


Klimoszek D, Jeleń M, Dołowy M, Morak-Młodawska B (2024) Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents. Pharmaceuticals 17(6):725. https://doi.org/10.3390/ph17060725


Larrosa M, Yanez-Gascon MJ, Selma MV, Gonzalez-Sarrias A, Toti S, Ceron JJ et al (2009) Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J Agric Food Chem 57:2211–2220. https://doi.org/10.1021/jf803638d


Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8(7):634–646. https://doi.org/10.2174/156800908786241050


Liu X, Sun R, Li Z, Xiao R, Lv P, Sun X et al (2021) Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. Arch Biochem Biophys 711:109019. https://doi.org/10.1016/j.abb.2021.109019


Mogana R, Teng-Jin K, Wiart C (2013) The medicinal timber Canarium patentinervium Miq. (Burseraceae Kunth) is an anti-inflammatory bioresource of dual inhibitors of cyclooxygenase (COX) and 5-lipoxygenase (5-LOX). Int Sch Res Not 213(1):986361


Parra C, Soto E, León G, Salas CO, Heinrich M, Echiburú-Chau C (2018) Nutritional composition, antioxidant activity and isolation of scopoletin from Senecio nutans: support of ancestral and new uses. Nat Prod Res 32(6):719–722


Ran LS, Wu YZ, Gan YW, Wang HL, Wu LJ, Zheng CM et al (2023) Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease. J Nat Med 77(1):73–86. https://doi.org/10.1007/s11418-022-01647-w


Rayalam S, Yang JY, Ambati S, Della-Fera MA, Baile CA (2008) Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22:1367–1371. https://doi.org/10.1002/ptr.2503


Sarveswaran S, Gautam SC, Ghosh J (2012) Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt. Int J Oncol 41(6):2191–2199. https://doi.org/10.3892/ijo.2012.1664


Song B, Niu W, Zhang S, Hao M, Li Y, Chen Q et al (2024) A mechanistic review of the pharmacological aspects of Kaempferide as a natural compound. Heliyon 10(19):e38243


Sulaiman CT, Balachandran I (2015) Chemical profiling of an Indian herbal Formula using liquid chromatography coupled with electro spray ionization mass spectrometry. Spectrosc Lett 48:222–226. https://doi.org/10.1080/00387010.2013.872670


Sulaiman CT, George S, Thushar KV, Balachandran I (2014) Phenolic characterization of selected Salacia species using LC-ESI-MS/MS analysis. Nat Prod Res 28:1021–1024


Sulaiman CT, Ramesh PR, Mahesh K, Madhu KM, Anandan EM, Praveen M, Balachandran I (2020) Chemical profiling of a polyherbal formulation by tandem mass spectroscopic analysis with multiple ionization techniques. Future J Pharm Sci. https://doi.org/10.1186/s43094-020-00062-w


Tan P, Jin L, Qin X, He B (2022) Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease. Front Pharmacol 13:1005312


Tie F, Ding J, Hu N, Dong Q, Chen Z, Wang H (2021) Kaempferol and Kaempferide attenuate oleic acid-induced lipid accumulation and oxidative stress in HepG2 cells. Int J Mol Sci 22(16):8847. https://doi.org/10.3390/ijms22168847


Vinyagam R, Kumar P, Lee KE, Xu B, Matin MN, Kang SG (2021) Biological and functional properties of wedelolactone in human chronic diseases. Phyton 90(1):1


Wang P, Li DT, Ke WX, Liang D, Hu XS, Chen F (2020) Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. Int J Obes 44:213–225. https://doi.org/10.1038/s41366-019-0332-1


Wang MQ, Zhang KH, Liu FL, Zhou R, Zeng Y, Chen AL et al (2024) Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress. Phytomed Int J Phytother Phytopharmacol 122:155124. https://doi.org/10.1016/j.phymed.2023.155124


Xiao B, Ma W, Zheng Y, Li Z, Li D, Zhang Y et al (2021) Effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats. Nutr Res Pract 15:26–37. https://doi.org/10.4162/nrp.2021.15.1.26


Xu Y, Nie L, Yin YG, Tang JL, Zhou JY, Li DD et al (2012) Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol Appl Pharmacol 259:395–401. https://doi.org/10.1016/j.taap.2011.09.028


Yao YX, Yu YJ, Dai S, Zhang CY, Xue XY, Zhou ML et al (2024) Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis. Biomed Pharmacother 175:116694


Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84


Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, Bugianesi E (2018) Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11–20


Zhang W, Gao K, Bai Y, Xu D, Zhao M, Tao X et al (2024) Wedelolactone attenuates liver fibrosis and hepatic stellate cell activation by suppressing the Hippo pathway. Rejuvenation Res 27(6):207–219


Zhao Y, Peng L, Yang LC, Xu XD, Li WJ, Luo XM et al (2015) Wedelolactone regulates lipid metabolism and improves hepatic steatosis partly by AMPK activation and up-regulation of expression of PPARα/LPL and LDLR. PLoS ONE 10(7):e0132720


Zhou SF (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38(7–8):802–832. https://doi.org/10.1080/00498250701867889

 

Author Information

---

Department of Dravyagunavijnanam, VPSV Ayurveda College, Kottakkal, India